Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Revenue

In the year 2024, Fennec Pharmaceuticals had annual revenue of $47.54M with 123.69% growth. Fennec Pharmaceuticals had revenue of $7.93M in the quarter ending December 31, 2024, a decrease of -18.59%.

• Revenue (ttm): $47.54M
• Revenue Growth: +123.69%
• P/S Ratio: 3.24
• Revenue / Employee: $1,485,563
• Employees: 32
• Market Cap: 155.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	47.54M	26.29M	123.69%
Dec 31, 2023	21.25M	19.72M	1,284.50%
Dec 31, 2022	1.54M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	170.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.